ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000014 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 11, 2026 |
| Document | View SEC Filing |
Transactions
22
Total Shares
28,580
Total Value
$3,475,156.51
P&L
+inf% (+$5,932,166.51)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 11, 2026 | Grant/Award | 19,003 | $0.00 | $0.00 | 87,988 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 247 | $353.95 | $87,425.65 | 87,741 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 269 | $355.16 | $95,538.04 | 87,472 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 263 | $356.09 | $93,651.67 | 87,209 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 607 | $357.17 | $216,802.19 | 86,602 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 778 | $358.18 | $278,664.04 | 85,824 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 537 | $359.14 | $192,858.18 | 85,287 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 980 | $360.22 | $353,015.60 | 84,307 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 624 | $361.45 | $225,544.80 | 83,683 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 464 | $362.38 | $168,144.32 | 83,219 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 301 | $363.55 | $109,428.55 | 82,918 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 1,259 | $364.83 | $459,320.97 | 81,659 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 1,395 | $365.56 | $509,956.20 | 80,264 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 316 | $366.41 | $115,785.56 | 79,948 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 261 | $367.40 | $95,891.40 | 79,687 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 584 | $368.62 | $215,274.08 | 79,103 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 253 | $369.48 | $93,478.44 | 78,850 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 118 | $370.87 | $43,762.66 | 78,732 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 21 | $372.46 | $7,821.66 | 78,711 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 88 | $374.44 | $32,950.72 | 78,623 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 118 | $375.65 | $44,326.70 | 78,505 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 12, 2026 | Sale | 94 | $377.82 | $35,515.08 | 78,411 | Direct | โ | View Details |